Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,915,087
+$763,808 QoQ
Shares Held
172,998
+15.0% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#48
of 199 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $199,313,913 across 163 Biotechnology names. REPL ranks #28 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
126,044 | $13,438,811 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
181,647 | $10,393,841 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,469 | $10,075,173 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,918 | $9,925,509 | |
| 5 | RPRX |
Royalty Pharma plc
|
137,994 | $7,737,323 | |
| 6 | EXEL |
Exelixis, Inc.
|
110,353 | $6,004,306 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
16,302 | $4,645,580 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
108,139 | $4,640,244 |
All Filings in REPL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,915,087 | 172,998 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,151,279 | 150,494 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $325,172 | 29,669 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $204,120 | 22,680 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $314,858 | 18,402 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $345,722 | 14,889 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $182,474 | 10,566 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $249,439 | 14,270 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $433,805 | 25,548 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||